<i>miR-375</i> Is Activated by ASH1 and Inhibits YAP1 in a Lineage-Dependent Manner in Lung Cancer

Eri Nishikawa(Nagoya University Hospital), Hirotaka Osada(Nagoya University Hospital), Yasumasa Okazaki(Nagoya University Hospital), Chinatsu Arima(Nagoya University Hospital), Shuta Tomida(Nagoya University Hospital), Yoshio Tatematsu(Nagoya University Hospital), Ayumu Taguchi(Nagoya University Hospital), Yukako Shimada(Nagoya University Hospital), Kiyoshi Yanagisawa(Nagoya University Hospital), Yasushi Yatabe(Nagoya University Hospital), Shinya Toyokuni(Nagoya University Hospital), Yoshitaka Sekido(Nagoya University Hospital), Takashi Takahashi(Nagoya University Hospital)
Cancer Research
August 19, 2011
Cited by 137

Abstract

Lung cancers with neuroendocrine (NE) features are often very aggressive but the underlying molecular mechanisms remain elusive. The transcription factor ASH1/ASCL1 is a master regulator of pulmonary NE cell development that is involved in the pathogenesis of lung cancers with NE features (NE-lung cancers). Here we report the definition of the microRNA miR-375 as a key downstream effector of ASH1 function in NE-lung cancer cells. miR-375 was markedly induced by ASH1 in lung cancer cells where it was sufficient to induce NE differentiation. miR-375 upregulation was a prerequisite for ASH1-mediated induction of NE features. The transcriptional coactivator YAP1 was determined to be a direct target of miR-375. YAP1 showed a negative correlation with miR-375 in a panel of lung cancer cell lines and growth inhibitory activities in NE-lung cancer cells. Our results elucidate an ASH1 effector axis in NE-lung cancers that is functionally pivotal in controlling NE features and the alleviation from YAP1-mediated growth inhibition.


Related Papers